Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
Farmers Insurance
Harvard Business School
Daiichi Sankyo
McKesson
Citi
Argus Health
Boehringer Ingelheim
Covington

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,216,178

« Back to Dashboard

Which drugs does patent 9,216,178 protect, and when does it expire?

Patent 9,216,178 protects KUVAN and is included in one NDA.
Summary for Patent: 9,216,178
Title:Dry blend formulation of tetrahydrobiopterin
Abstract: Dry blend powder formulations comprising a pharmaceutical formulation containing tetrahydrobiopterin, and methods of making and using the same, are disclosed herein.
Inventor(s): Chou; Tianwei (El Cerrito, CA), Okhamafe; Augustus O. (Concord, CA)
Assignee: BioMarin Pharmaceutical Inc. (Novato, CA)
Application Number:13/666,697
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 9,216,178

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Argus Health
Baxter
McKesson
Colorcon
Boehringer Ingelheim
Medtronic
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot